Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

INDVR Brands Inc CAAOF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
INDVR Brands Inc is focused on providing personnel and management resources as well as infrastructure and equipment for use in the production, cultivation and dispensary operations of licensed cannabis businesses. It provides support services to licensed cannabis businesses.


GREY:CAAOF - Post by User

INDVR Brands Inc > Revenue
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(100)
•••
Comment by GajjarDron May 29, 2019 9:55am
109 Views
Post# 29781284

RE:Revenue

RE:Revenue
bmorganstock wrote:
Cannabis One has conservatively estimated system wide revenue of US$116MM for 2019, and US$289MM for 2020, which puts them at under 2x sales prior to completing the acquisitions(3/31/2019).


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities